To compare observed and expected pediatric viral acute respiratory infection (ARI)-related hospitalizations and the characteristics of admitted children post-pandemic (definition needed).
Key Findings:
Significant reduction in ARIs in 2020/2021, followed by a moderate increase in 2021/2022, with a notable resurgence of RSV and human metapneumovirus in 2022/2023.
Interpretation:
Post-pandemic disruptions have significantly altered the epidemiology of pediatric ARIs, affecting the timing and characteristics of hospitalizations (specific changes needed).
Limitations:
Study limited to Ontario, which may not generalize to other regions.
Potential underreporting of non-hospitalized cases.
Possible biases in administrative data affecting results.
Conclusion:
The COVID-19 pandemic has led to substantial changes in the patterns of pediatric respiratory viruses, impacting healthcare demands and characteristics of affected children.
Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.